肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

遗传性乳腺癌和卵巢癌风险的修饰因子

Modifiers of risk of hereditary breast and ovarian cancer

原文发布日期:2002-02-01

DOI: 10.1038/nrc726

类型: Review Article

开放获取: 否

要点:

要点翻译:

英文摘要:

摘要翻译: 

原文链接:

文章:

遗传性乳腺癌和卵巢癌风险的修饰因子

Modifiers of risk of hereditary breast and ovarian cancer

原文发布日期:2002-02-01

DOI: 10.1038/nrc726

类型: Review Article

开放获取: 否

 

要点:

  1. Most, but not all, women who carry deleterious mutations in BRCA1 or BRCA2 will develop breast or ovarian cancer. The risk of cancer among mutation carriers varies between families and countries. Several study designs can be used to estimate disease penetrance and modifiers of penetrance.
  2. Reasons for variation include different mutations in the same gene (allelic variation) and the effect of modifying genes.
  3. Genetic modifiers of breast cancer risk include the androgen receptor, the steroid-hormone receptor coactivator NCOA3 and possibly the DNA-repair gene RAD51.
  4. Genetic modifiers of ovarian cancer risk include the HRAS1 oncogene and, possibly, the androgen receptor.
  5. Preventive oophorectomy, a non-genetic modifier, reduces the risk of ovarian cancer and of breast cancer in BRCA1-mutation carriers.
  6. Non-genetic modifiers of breast cancer risk include tamoxifen and reproductive history (such as parity and breastfeeding).
  7. Non-genetic modifiers of ovarian cancer risk include oral contraceptives and (in BRCA1-mutation carriers) tubal ligation.

 

要点翻译:

  1. 大多数(但非全部)携带BRCA1或BRCA2有害突变的女性会发展为乳腺癌或卵巢癌。突变携带者的癌症风险因家族和国家而异。可采用多种研究设计评估疾病外显率及其修饰因素。
  2. 风险差异的成因包括同一基因的不同突变(等位基因变异)以及修饰基因的影响。
  3. 乳腺癌风险的遗传修饰因子包括雄激素受体、类固醇激素受体共激活因子NCOA3,可能还包括DNA修复基因RAD51。
  4. 卵巢癌风险的遗传修饰因子包含HRAS1癌基因,可能还涉及雄激素受体。
  5. 预防性卵巢切除术(非遗传修饰因子)可降低BRCA1突变携带者的卵巢癌和乳腺癌风险。
  6. 乳腺癌的非遗传修饰因素包括他莫昔芬药物和生育史(如产次和哺乳史)。
  7. 卵巢癌的非遗传修饰因素则涵盖口服避孕药及(针对BRCA1突变携带者的)输卵管结扎术。

 

英文摘要:

Hereditary breast and ovarian cancer is among the most commonly encountered adult genetic disease, and it is increasingly important that geneticists, oncologists, surgeons and gynaecologists are aware of the issues regarding risk assessment, prevention and management of women with inherited susceptibility to cancer. Genetic risk can be modified by external factors, but what are these factors, and how might our knowledge of them help us to better define the risks for individual women and to develop strategies for cancer prevention?

摘要翻译: 

遗传性乳腺癌和卵巢癌是最常见的成人遗传病之一,遗传学家、肿瘤科医生、外科医生和妇科医生必须熟悉风险评估、预防以及管理具有癌症遗传易感性的女性所涉及的问题。遗传风险可受外部因素修饰,但这些因素是什么?我们对其了解又如何有助于更准确地界定个体女性的风险,并制定癌症预防策略?

原文链接:

Modifiers of risk of hereditary breast and ovarian cancer

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……